The Effect of Single Clove Garlic Extract (Allium sativum) Against Aspartame-Induced Hepatotoxicity in Diabetic Rats
DOI:
https://doi.org/10.59167/tujnas.v8i2.1716Keywords:
Alloxan, Single Clove Garlic, Hepatotoxicity, AspartameAbstract
Background: Aspartame is a widely used synthetic sweetener used for dietary control and by diabetics. Objectives: This study aims to investigate the effect of a single garlic clove extract against aspartame-induced hepatotoxicity in diabetic rats. Methods: Forty-eight experimental male albino rats were randomly divided into eight groups (6 rats per group) as follows: Group (G)1: served as normal control and received distilled water orally, G2: rats treated with single clove garlic (SCG) extract (0.5 g/kg body weight), G3: rats were treated with SCG extract (0.5 g/kg body weight) and alkaline phosphatase (ALP) (200 mg/kg body weight), G4: rats treated with ASP (200 mg/kg body weight), G5: was the diabetic control group (induced by alloxan (ALX) 120 mg/kg body weight), G6: diabetic rats were treated with SCG extract (0.5 g/kg body weight), G7: diabetic rats were treated with SCG extract (0.5 g/kg body weight) and ASP (200 mg/kg body weight) and G8: diabetic rats were treated with ASP 200 mg/kg body weight. Results: The results obtained showed that treatment with ASP caused a significant increase in serum levels of serum alanine transaminase (ALT), aspartate transaminase (AST), and ASP in SCG extract-treated rats in G3 and G4 and diabetic rats in G7 and G8, while treatment with SCG extract caused a significant decrease in serum levels of ALT, AST and ALP in SCG treated rats in G2 and G6 and diabetic rats in G7 compared to the control group (G1). After treatment with ASP, histologic changes in the liver were observed in G4, which were more pronounced in G8, indicating liver damage compared to the control group, while treatment with SCG extract showed further changes in liver tissue in the diabetic rats of G7 and G8. Conclusion: The present study suggests that administering ASP in normal rats leads to liver dysfunction. Moreover, our results proved that the application of ASP in diabetic rats may cause additional damage compared to ASP in normal rats. This study demonstrated that treatment with SCG extract significantly attenuated the biochemical and histopathologic changes induced by ASP and alloxan. From the data obtained, it appears that treatment with SCG extract has a protective effect against the toxicity of ASF and alloxan on the liver of normal and diabetic rats.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2023 Mohammed Ahmed Qasim, Fahmi S. Moqbel, Nada M. H. Al Hamdani
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
From July 2025 onward, all TUJNAS publications are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This open license allows anyone to share (copy and redistribute) and adapt (remix, transform, and build upon) the work in any medium or format, for any purpose (even commercially), as long as appropriate credit is given to the original author(s) and source. This permissive framework encourages scholarly innovation, translation, and integration into wider academic outputs by removing unnecessary legal barriers. Users of TUJNAS content must provide proper attribution and indicate if any changes were made to the original work. By enabling unrestricted reuse, the CC BY 4.0 license maximizes the reach and impact of research findings while ensuring that authors receive full recognition for their work. (For complete legal details of the CC BY 4.0 license, please refer to the official Creative Commons website.)
Submissions (from July 2025 onward): By submitting a manuscript to TUJNAS for publication (Volume 10, Issue 2, 2025 and thereafter), authors confirm the following:
- Originality: The submission is original, has not been published elsewhere, and is not under consideration by another journal.
- Copyright Retention: The author(s) retain copyright of the work, but grant TUJNAS a non-exclusive right to publish, reproduce, distribute, and archive the article.
- Open Access License: Upon acceptance, the article will be published open access under the CC BY 4.0 license.
- Repository Deposit: The author(s) agree that the full text and metadata of the article may be deposited in digital archives or repositories, to facilitate indexing and reuse under the CC BY 4.0 license.
- Indexing and Sharing: The author(s) acknowledge that TUJNAS may make the article available to third-party indexing, abstracting, and discovery services under the CC BY 4.0 license, without the need for additional permission.
These submission terms ensure that authors understand and consent to the open-access, licensed nature of TUJNAS publications from the outset.
How to Cite
